Skip to main content
. 2018 Jun;50(2):77–82.

Figure 2.

Figure 2.

Panel A shows a gel electrophoresis from the patient in case 1 while Impella 5.0 was in place (lane 22), from the same patient following device removal (lane 12), from a healthy control (lane 14), and from a patient with type 2B VWS (lane 15). Panel B shows a gel electrophoresis from the patient in case 17 before Impella 5.0 implant (lane 18), from a healthy control (lane 14), from a patient with type 2B VWS (lane 15), and from the patient in case 17 with the Impella in place (lane 7). In both cases, HMWMs disappear during MCS and resemble the distribution of the patient with type 2B VWS.